Immunoassays

This protocol details the procedure for testing samples with the OLM Aspergillus LFD (AspLFD). The following protocol is summarised in the figure overleaf. Please see the AspLFD handbook for more detailed product information.

The Chikungunya Virus IgG capture ELISA is intended for the qualitative determination of IgG class antibodies against Chikungunya Virus in human serum or plasma (citrate, heparin).

The Chikungunya Virus IgM μ-capture ELISA is intended for the qualitative determination of IgM class antibodies against Chikungunya Virus in human serum or plasma (citrate, heparin).

The Epstein-Barr Virus (VCA) IgA ELISA is intended for the qualitative determination of IgA class antibodies against Epstein-Barr Virus viral capsid antigen (VCA) in human serum or plasma (citrate, heparin).

The Influenza Virus A IgA ELISA is intended for the qualitative determination of IgA class antibodies against Influenza Virus A in human serum or plasma (citrate, heparin).

The Influenza Virus B IgM ELISA is intended for the qualitative determination of IgM class antibodies against Influenza Virus B in human serum or plasma (citrate, heparin).

Der Influenza Virus A IgM ELISA ist für den qualitativen Nachweis spezifischer IgM-Antikörper gegen Influenza Virus A in humanem Serum oder Plasma (Citrat, Heparin) bestimmt.

The Bordetella pertussis IgA ELISA is intended for the qualitative determination of IgA class antibodies against Bordetella pertussis in human serum or plasma (citrate, heparin).

The Bordetella pertussis IgG ELISA is intended for the qualitative determination of IgG class antibodies against Bordetella pertussis in human serum or plasma (citrate, heparin).

The Bordetella pertussis IgM ELISA is intended for the qualitative determination of IgM class antibodies against Bordetella pertussis in human serum or plasma (citrate, heparin).